• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [16962 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Single/two-step scaffold-based cartilage repair in the knee and ankle joint
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Radiofrequency denervation for lumbar and cervical facet joint pain – a systematic review
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Upper Airway Stimulation for Moderate-to-Severe Sleep Apnea. 1st Update 2019
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osteochondral allograft transplantation for the knee (or other joints)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allograft for anterior and posterior cruciate ligament reconstruction
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Human dermal allograft for massive rotator cuff tears
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) 177Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Custom-made or customisable 3D printed implants and cutting guides versus non- 3D printed standard implants and cutting guides for improving outcome in patients undergoing knee, maxillofacial, or cranial surgery
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Brentuximab vedotin (Adcetris®) in combination with chemotherapy for CD30-positive peripheral T-cell lymphoma (PTCLs)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Irreversible electroporation for the treatment of liver and pancreatic cancer
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening and prevention programmes for children and adolescents from 6 to 14 years. Results from selected countries and recommendations from evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening for Diabetes mellitus: guideline recommendations
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Public & philanthropic financial contribution to the development of new drugs: Methodology & 3 Case Studies
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) FoundationOne®CDx: genetic profiling of solid tumours
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Sponsoring of Patient Initiatives in Austria 2018. Update of the Systematic Analyses 2014, 2015 and 2016
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pharma: Disclosure of transfers of value in Austria 2018. Update of the systematic analysis 2015
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) as first-line therapy for PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (NSCLC)
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Screening programs for children and adolescents from 6 to 18 years. Results on selected countries, Austrian screening programmes and recommendations from evidence-based guidelines
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cervical Carcinoma Prevention - Implementation of an HPV screening test for early detection of cervical cancer in Austria
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) POCT/ Point of Care Tests: D-Dimer and Troponin
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Minimum volume standards for quality assurance in day surgery: Fundamentals and Systematic Review
2019     Center for Drug Evaluation (CDE) Assessment of the benefits of community day-care facilities for the physically and mentally handicapped
2019     Adelaide Health Technology Assessment (AHTA) Faecal calprotectin testing in patients suspected of inflammatory bowel disease (IBD) presenting to primary care
2019     Adelaide Health Technology Assessment (AHTA) Immunoglobulin for myasthenia gravis
2019     Adelaide Health Technology Assessment (AHTA) Immunoglobulin for acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (HSCT)
2019     Health Quality Ontario (HQO) Intermittent Catheters for Chronic Urinary Retention: A Health Technology Assessment
2019     Health Quality Ontario (HQO) Compression Stockings for the Prevention of Venous Leg Ulcer Recurrence: A Health Technology Assessment
2019     Adelaide Health Technology Assessment (AHTA) Heritable Mutations associated with Familial Hypercholesterolaemia
2019     Health Quality Ontario (HQO) Cervical Artificial Disc Replacement Versus Fusion for Cervical Degenerative Disc Disease: A Health Technology Assessment
2019     Technology Assessment at SickKids (TASK) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in autism spectrum disorder: an update
2019     Technology Assessment at SickKids (TASK) The economic evaluation of early intervention with anti-tumor necrosis factor-α treatments in pediatric Crohn's disease
2019     Technology Assessment at SickKids (TASK) A cost-utility analysis of biosimilar infliximab compared to reference infliximab in adult switch patients with Crohn’s disease: a Canadian analysis
2019     Health Quality Ontario (HQO) Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment
2019     Health Technology Wales (HTW) Continuous glucose monitoring systems for managing diabetes in pregnant women
2019     Health Quality Ontario (HQO) Perspectives of Pregnant People and Clinicians on Noninvasive Prenatal Testing: A Systematic Review and Qualitative Meta-synthesis
2019     Health Technology Wales (HTW) Pharmacogenetic testing to identify the risk of adverse reactions to anti-epileptic medications
2019     Health Quality Ontario (HQO) Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment
2019     Health Technology Wales (HTW) Robot-assisted thoracic surgery
2019     Ontario Health Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment
2019     Health Technology Wales (HTW) Occipital nerve stimulation for medically refractory chronic cluster headache
2019     Health Sciences Institute in Aragon (IACS) Efficacy, effectiveness and safety of intraoperative radiotherapy in breast carcinoma
2019     Health Sciences Institute in Aragon (IACS) Detection of diabetes' complications. Diabetic retinopathy. Economic evaluation of ultra-wide field scanning laser
2019     Health Technology Wales (HTW) Multi-grip myoelectric upper-limb prosthetics
2019     Ontario Health Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment
2019     Ontario Health Minimally Invasive Glaucoma Surgery: A Budget Impact Analysis and Evaluation of Patients’ Experiences, Preferences, and Values
2019     Belgian Health Care Knowledge Centre (KCE) Polyvalent immunoglobulins – Part 1: A rapid review
2019     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Enzalutamide (prostate cancer) - Addendum to Commission A18-80]
2019     Basque Office for Health Technology Assessment (OSTEBA) Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements
2019     Basque Office for Health Technology Assessment (OSTEBA) Indications, utility and use of ultrasound in primary care
2019     Basque Office for Health Technology Assessment (OSTEBA) Controlled and uncontrolled donation after circulatory death with regional normothermic or hypothermic perfusion based on extracorporeal membrane oxygenation for kidney and liver transplants
2019     Belgian Health Care Knowledge Centre (KCE) Bariatric surgery : an HTA report on the efficacy, safety and cost-effectiveness
2019     Basque Office for Health Technology Assessment (OSTEBA) Methodological project: Synthesis of information in support of multicriteria decision analysis (MCDA) for decision making
2019     Belgian Health Care Knowledge Centre (KCE) Cost-effectiveness analysis of HPV vaccination of boys in Belgium
2019     Belgian Health Care Knowledge Centre (KCE) The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
2019     Belgian Health Care Knowledge Centre (KCE) Proton beam therapy in adults
2019     Belgian Health Care Knowledge Centre (KCE) Statins for the primary prevention of cardiovascular events
2019     NIHR Health Services and Delivery Research programme Developing a reporting guideline to improve meta-ethnography in health research: the eMERGe mixed-methods study
2019     NIHR Health Services and Delivery Research programme Innovation to enhance health in care homes and evaluation of tools for measuring outcomes of care: rapid evidence synthesis
2019     NIHR Health Services and Delivery Research programme Digital and online symptom checkers and assessment services for urgent care to inform a new digital platform: a systematic review
2019     NIHR Health Services and Delivery Research programme Improving care for women and girls who have undergone female genital mutilation/cutting: qualitative systematic reviews
2019     NIHR Health Services and Delivery Research programme Multicomponent hospital-led interventions to reduce hospital stay for older adults following elective surgery: a systematic review
2018     NIHR Health Technology Assessment programme Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT
2018     NIHR Health Technology Assessment programme Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: systematic reviews and economic evaluation
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sofosbuvir (hepatitis C in adolescents) - benefit assessment according to §35a Social Code Book V]
2018     NIHR Health Technology Assessment programme Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (renal cell carcinoma) - benefit assessment according to §35a Social Code Book V]
2018     NIHR Health Technology Assessment programme Brain and spinal stimulation therapies for phantom limb pain: a systematic review
2018     NIHR Health Technology Assessment programme Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Obinutuzumab (non-pretreated advanced follicular lymphoma) - assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Midostaurin (acute myeloid leukaemia) - assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Telotristat ethyl (carcinoid syndrome diarrhoea) - benefit assessment according to §35a (1), sentence 11, Social Code Book V]
2018     NIHR Health Technology Assessment programme Contrast-enhanced ultrasound and/or colour duplex ultrasound for surveillance after endovascular abdominal aortic aneurysm repair: a systematic review and economic evaluation
2018     Center for Evidence-based Practice (CEP) Guidelines for Electrocardiography on Arrival to the Emergency Department
2018     Center for Evidence-based Practice (CEP) Guidelines for Management of Acute Hydronephrosis
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Dropouts in Psychotherapy. Part I: Predictors, theories and models to explain and recommend courses of action to avoid discontinuation of therapy. Part II: "Overview of Reviews" on dropouts in psychotherapy
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Options to identify inappropriate use of MRI, Part 3
2018     NIHR Public Health Research (PHR) programme Child food insecurity in the UK: a rapid review
2018     Adelaide Health Technology Assessment (AHTA) Extended half-life clotting factor concentrates for the treatment of haemophilia A and B
2018     Adelaide Health Technology Assessment (AHTA) Anti-Mullerian Hormone (AMH) testing for female patients who will or have received gonadotoxic treatment
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Osimertinib (Tagrisso®) for the initial treatment of EGFR-mutated advanced non–small-cell lung cancer (NSCLC)
2018     Norwegian Institute for Public Health EXOGEN™ in the treatment of non-union fractures. A single technology assessment
2018     Norwegian Institute for Public Health Effectiveness and safety of nitrous oxide as sedation regimen in children – an HTA
2018     Norwegian Institute for Public Health Autologous hematopoietic stem cell transplantation (AHSCT) for Diffuse Systemic Sclerosis. Health Technology Assessment
2018     Norwegian Institute for Public Health The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment
2018     Norwegian Institute for Public Health 177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment
2018     Norwegian Institute for Public Health Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment
2018     Norwegian Institute for Public Health Bariatric surgery for Type 2 Diabetes and a body mass index below 35
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Daratumumab (Darzalex®) in combination with bortezomib, melphalan and prednisone for untreated myeloma
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Endobronchial valve implantation for emphysema. Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) High-intensity focused ultrasound for the treatment of prostate cancer. 1st Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) (Percutaneous) left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation. 3rd Update 2018
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Subcutaneous implantable cardioverter defibrillator (ICD)
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Lymphovenous anastomoses in patients with primary and secondary lymphoedema
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Allogeneic mesenchymal stem cells for Crohn’s disease-associated complex perianal fistulas